Logo Resized for Globe Newswire2.jpg
Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy
February 27, 2024 08:30 ET | Wave Life Sciences USA, Inc.
Presentations include data for WVE-N531 that provide first clinical evidence of a potential therapeutic for DMD accessing satellite cells, which are important for potential muscle regeneration ...
Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea
February 27, 2024 08:00 ET | Healis Therapeutics
CKDB-501A, a novel BoNT/A neuromodulator protein, completed a Phase 3 trial to investigate the efficacy and safety in treating the glabella.
22157.jpg
Clinical Trials and What to Expect in 2024: Preview of Trials Planned to Initiate and Estimated to Complete
February 21, 2024 10:55 ET | Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete" report has been added to ...
calian_logo.jpg
Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate
February 20, 2024 16:35 ET | Calian Group Ltd.
Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate
calian_logo.jpg
Calian remporte un contrat pour soutenir l’essai clinique du principal médicament candidat de ZYUS Life Sciences
February 20, 2024 16:35 ET | Calian Group Ltd.
OTTAWA, 20 févr. 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX : CGY), une société de solutions diversifiées qui fournit des produits et des services innovants dans les domaines de la santé,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Data to be Published in ACS Chemical Neuroscience
February 20, 2024 08:55 ET | PharmAla Biotech
PharmAla's drug discovery data to be published in ACS Chemical Neuroscience; PharmAla presents data at ISRP Conference in New Orleans
Transparency Market Research
Horseradish Peroxidase Market Set to Reach USD 100 million by 2031, Surging at a 7.3% CAGR - Transparency Market Research, Inc.
February 19, 2024 09:40 ET | Transparency Market Research
Wilmington, Delaware, United States, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for horseradish peroxidase is anticipated to attain a valuation of US$...
22157.jpg
In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities
February 16, 2024 04:09 ET | Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Life-Science Analytics Market Size is Expected to Surpass the USD 20.9 Billion By 2033; CAGR of 8.0%
February 12, 2024 07:54 ET | Market.Us
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Life-Science Analytics Market size is projected to exceed USD 20.9 Billion by 2033, and it is poised to reach a...
h1-logo-main (1).png
H1 Honored With Spot On the New York Digital Health 100 For Third Straight Year
February 08, 2024 09:00 ET | H1
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global healthcare professionals, clinical trial, and research information for life sciences, today announced that it...